Lifestyle Guidance Methods in NAFLD

To determine the efficiency of lifestyle modification (due to a dietitian or digital application) compared to standard of care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-Alcoholic Fatty Liver Disease Digestive System Diseases Fatty Liver Liver Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ziekenhuis Oost-Limburg

Genk, Limburg, 3600, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

NAFLD based in FibroScan measurements

Exclusion criteria

excessive alcohol use
other causes of liver disease
secondary causes of liver steatosis

Treatment and study plan

Coach

Behavioral

Coaching to a healthy lifestyle

App

Behavioral

The app will coach people to a healthy lifestyle

Standard of care

Other

Patients will receive standardized lifestyle advice by their specialist

Primary outcomes

A change in liver fat

Time frame: 1 year

As measured by the controlled attenuation parameter in the intervention arms as compared to standard of care

Sponsors and collaborators

Lead sponsor

Ziekenhuis Oost-Limburg

Other

Registry information

Official study title

The Investigation of Different Guidance Methods to Facilitate Lifestyle Changes in Patients With NAFLD

Acronym: INDIANA

Important dates

Study start: 2022
Primary completion: 2025
Study completion: 2025
First posted: Mar 31, 2023
Registry last updated: Jul 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed